CyFlow™ CD35 FITC

CyFlow™ CD35 FITC

Catalog Number:
A001343611SYS
Mfr. No.:
BL832690
Price:
$456
  • Size:
    100 tests (0.4 mL)
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          CD35 (CR1; complement receptor 1) is a monomeric multiple modular cell surface glycoprotein which serves as receptor for C3b and C4b, the most important components of the complement system leading to clearance of foreign macromolecules. It is expressed mainly on the surface of granulocytes, monocytes, erythrocytes, B cells and folicular dendritic cells. Besides its role in complement cascade, CD35 is involved in blocking BCR-induced proliferation and the differentiation of B cells to plasmablasts and their Ig production.

      • Properties
        • Host
          mouse
          Antibody Type
          monoclonal
          Isotype
          IgG1
          Reactivity
          human; non-human primates
          Clone
          E11
          Immunogen
          Acute monocytic leukemia cells and normal blood monocytes
          Conjugate
          FITC
          Formulation
          The reagent is provided in stabilizing phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
          Storage
          Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
          Regulatory Status
          RUO
          Antigen
          C3b/C4b-R, CR1

          * Research use only

      • Applications
        • Application
          Flow Cytometry
          Application Description
          The reagent is designed for Flow Cytometry analysis of human blood cells. Recommended usage is 4·µl reagent·/ 100·µl of whole blood or 10^6 cells in a suspension. The content of a vial (0.4 ml) is sufficient for 100 tests.

          Emission Maximum: 518 nm
          Excitation Maximum: 490 to 495 nm

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.